Showing results (1111-1120 of 1,217) with videos related to
Sort By:
Pageof 122
Biorxiv : the Preprint Server for Biology|August 12, 2025
Huntington's disease LIG1 modifier variant increases ligase fidelity and suppresses somatic CAG repeat expansionEunhye Lee, Wonju Kim, David H Beier, et al.Brain Communications|March 7, 2024
Modification of Huntington's disease by short tandem repeatsEun Pyo Hong, Eliana Marisa Ramos, N Ahmad Aziz, et al.Nature|May 23, 2014
A Wolf-Rayet-like progenitor of SN 2013cu from spectral observations of a stellar windAvishay Gal-Yam, I Arcavi, E O Ofek, et al.Clinical Kidney Journal|May 7, 2021
The PrEscription of intraDialytic exercise to improve quAlity of Life in patients with chronic kidney disease trial: study design and baseline data for a multicentre randomized controlled trialSharlene A Greenwood, Pelagia Koufaki, Jamie Macdonald, et al.American Journal of Nephrology|December 19, 2017
The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline CharacteristicsMeg J Jardine, Kenneth W Mahaffey, Bruce Neal, et al.Neuroimage|May 21, 2013
The current state-of-the-art of spinal cord imaging: methodsP W Stroman, C Wheeler-Kingshott, M Bacon, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 11, 2020
Identifying critically important cardiovascular outcomes for trials in hemodialysis: an international survey with patients, caregivers and health professionalsEmma O'Lone, Martin Howell, Andrea K Viecelli, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 1997
High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomesC Wheeler, C Eickhoff, A Elias, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 8, 2023
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical TrialTae Won Yi, Brendan Smyth, Gian Luca Di Tanna, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 25, 2018
Scope and Consistency of Outcomes Reported in Randomized Trials Conducted in Adults Receiving Hemodialysis: A Systematic ReviewBénédicte Sautenet, Allison Tong, Gabrielle Williams, et al.Pageof 122